These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7408402)

  • 41. The diltiazem-digoxin interaction.
    Rameis H; Magometschnigg D; Ganzinger U
    Clin Pharmacol Ther; 1984 Aug; 36(2):183-9. PubMed ID: 6744777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered flecainide disposition in healthy volunteers taking quinine.
    Munafo A; Reymond-Michel G; Biollaz J
    Eur J Clin Pharmacol; 1990; 38(3):269-73. PubMed ID: 2111245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects.
    Nolan PE; Marcus FI; Erstad BL; Hoyer GL; Furman C; Kirsten EB
    J Clin Pharmacol; 1989 Jan; 29(1):46-52. PubMed ID: 2708548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacokinetics of digoxin in newborn and adult sheep.
    Berman W; Musselman J; Shortencarrier R
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):173-86. PubMed ID: 7120047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic evaluation of the digoxin-amiodarone interaction.
    Fenster PE; White NW; Hanson CD
    J Am Coll Cardiol; 1985 Jan; 5(1):108-12. PubMed ID: 3964797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of digoxin in sheep: limitations of the use of biological half-life for interspecies extrapolation.
    Dix LP; Bai SA; Rogers RA; Anderson DL; Riviere JE
    Am J Vet Res; 1985 Feb; 46(2):470-2. PubMed ID: 3994115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine.
    Gaudry SE; Sitar DS; Smyth DD; McKenzie JK; Aoki FY
    Clin Pharmacol Ther; 1993 Jul; 54(1):23-7. PubMed ID: 8330461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
    Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Digoxin quinidine interaction: a pharmacokinetic study in the isolated perfused rat liver.
    Ben-Itzhak J; Bassan HM; Shor R; Lanir A
    Life Sci; 1985 Aug; 37(5):411-5. PubMed ID: 4021722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal function and digoxin clearance during quinidine therapy.
    Schenck-Gustafsson K; Juhlin-Dannfelt A; Dahlqvist R
    Clin Physiol; 1982 Oct; 2(5):401-8. PubMed ID: 6890426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.
    Keller F; Kreutz G; Vöhringer HF; Offermann G; Distler A
    Clin Pharmacokinet; 1985; 10(6):514-23. PubMed ID: 4064450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of quinidine on digoxin bioavailability.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 24(1):41-7. PubMed ID: 6832200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of the digoxin-aspirin combination.
    Fenster PE; Comess KA; Hanson CD; Finley PR
    Clin Pharmacol Ther; 1982 Oct; 32(4):428-30. PubMed ID: 7116757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
    Su SF; Huang JD
    Drug Metab Dispos; 1996 Feb; 24(2):142-7. PubMed ID: 8742224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of spironolactone on the renal clearance of digoxin in dogs.
    O'Brien MS; Salamone LF; Gibson TP
    J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 57. Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration.
    Pedersen KE; Christiansen BD; Kjaer K; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1983 Jul; 34(1):8-13. PubMed ID: 6861442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacokinetics of digoxin.
    Iisalo E
    Clin Pharmacokinet; 1977; 2(1):1-16. PubMed ID: 322907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.
    Koren G; Klein J; Giesbrecht E; Ben Dayan R; Soldin S; Sellers E; MacLeod S; Silverman M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1193-8. PubMed ID: 3204514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.